Vivos Therapeutics Inc (NAS:VVOS)
$ 2.09 0.14 (7.18%) Market Cap: 6.75 Mil Enterprise Value: 5.56 Mil PE Ratio: 0 PB Ratio: 9.15 GF Score: 55/100

Q2 2023 Vivos Therapeutics Inc Earnings Call Transcript

Aug 16, 2023 / 10:00PM GMT
Release Date Price: $8.58 (+5.12%)
Operator

Good day, everyone and welcome to Vivos Therapeutics' second quarter earnings call. (Operator Instructions) This conference call is being recorded. And a replay of today's call will be available on the investor relation section of Vivo's website and will remain posted there for the next 30 days. I will now hand over the call to Julie Gannon, Vivos' Investor Relation officer for the introductions and the reading of the safe harbor statement. Please go ahead.

Julie Gannon
Vivos Therapeutics, Inc. - IR

Thank you, operator. Hello, everyone, and welcome to our conference call. A copy of our earnings press release is available on the Investor Relations section of our website at www.vivos.com. With us on today's call are Kirk Huntsman, Vivos Chairman and Chief Executive Officer, and Brad Amman, Chief Financial Officer.

Today, we'll review the highlights and financial results for the second quarter of 2023 as well as more recent developments and deals plans for the remainder of 2023. Following

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot